CalciMedica is trading 7.75% higher at $1.33 on October 26, 2026, with no company-specific catalyst reported for the pre-market rise.
- The reported CFO resignation was announced October 16, not October 26.
- Broader indexes are up modestly, but none has gained more than 0.5%, so the evidence does not establish a market-wide reason for the move.
- CalciMedica’s October 23 gain was also described as lacking a clear catalyst; the explanation for the current move remains unclear.